Beyond radiation resistance, HFDs promote cancer cell survival through obesity-driven hyperinsulinemia and chronic inflammation, which activate oncogenic pro-survival pathways, including PI3K/AKT and STAT3. The gene discussed is AKT1; the disease is obesity disorder.